Johnson & Johnson CEO Joins Apple Board | News

Alex Gorsky Joins Apple's Board of Directors
Alex Gorsky, formerly chairman and CEO of Johnson & Johnson, has been appointed to Apple’s board of directors. This appointment precedes his scheduled retirement as CEO of Johnson & Johnson in January 2022.
The timing of this addition aligns with Apple’s increasing emphasis on the development and integration of health technology.
Apple's Growing Focus on Health
Apple has demonstrably prioritized health and wellness initiatives, introducing numerous features geared towards health monitoring and improvement within both iOS and WatchOS over recent years. Consequently, Gorsky’s inclusion on the board is a logical progression.
Tim Cook, Apple’s CEO, highlighted Gorsky’s contributions in a press statement. He described Gorsky as a forward-thinking leader in healthcare, dedicated to leveraging technology for the betterment of public health and community wellness.
Gorsky's Background and Expertise
Gorsky’s career at Johnson & Johnson began in 1988, and he assumed the role of CEO in 2012. Apple emphasized his commitment to innovation and technological advancement.
His leadership has spurred investments that have significantly impacted the pharmaceutical, medical device, and consumer health industries.
Gorsky's Statement on Joining Apple
Gorsky expressed his alignment with Apple’s core philosophy regarding the potential of technology to positively influence lives and foster healthier communities. He conveyed his honor at joining the board.
He further stated his enthusiasm for contributing to a company driven by strong values and a continuous pursuit of innovation, aimed at improving daily life.
Key Takeaways
- Alex Gorsky, ex-Johnson & Johnson CEO, is now on Apple’s board.
- This move reflects Apple’s growing interest in health technology.
- Tim Cook praised Gorsky’s vision and experience.
- Gorsky’s leadership at Johnson & Johnson prioritized innovation.
Related Posts

LatAm Doctor Communication: Ex-Uber Eats Exec Raises $14M Seed

Chai Discovery Raises $130M Series B - AI Biotech Funding

Inito AI Antibodies: Expanding At-Home Fertility Testing

Brain Fitbit: Startup Tackles Chronic Stress with Wearable Tech

Max Hodak's New Venture: Beyond Neuralink
